Kathleen Moore to Neoplasm, Residual
This is a "connection" page, showing publications Kathleen Moore has written about Neoplasm, Residual.
Connection Strength
0.189
-
Contribution of age to clinical trial enrollment and tolerance with ovarian cancer. Gynecol Oncol. 2017 04; 145(1):32-36.
Score: 0.140
-
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer. Gynecol Oncol. 2022 04; 165(1):82-89.
Score: 0.050